drug
MK-1406
Phase 3updated 6mo agoby $MRK Merck & Co., Inc.
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying MK-1406
- phase1A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
- phase1A Trial to Evaluate the Effect of CD388/MK1406 on the Immunogenicity of Fluzone® HD Vaccine (CD388.SQ.1.08/MK-1406-007)
- phase3A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 36m ago
Found something off?
comments(0)
5-min edit window · permanent after that